SARS-CoV-2 infections and circulating viral strains in South Africa during SHERPA trial 2022–2023 (n = 15 392*).

<p>SARS-CoV-2 infections and circulating viral strains in South Africa during SHERPA trial 2022–2023 (n = 15 392*).</p>

Publication Details

Journal
Figshare
Published
2024-12-05
DOI
https://doi.org/10.1371/journal.pgph.0003260.s016
Primary Topic
SARS-CoV-2 detection and testing
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SARS-CoV-2 infections and circulating viral strains in South Africa during SHERPA trial 2022–2023 (n = 15 392*).

Figshare
SARS-CoV-2 detection and testing
article

SARS-CoV-2 infections and circulating viral strains in South Africa during SHERPA trial 2022–2023 (n = 15 392*).

article en

Abstract

<p>SARS-CoV-2 infections and circulating viral strains in South Africa during SHERPA trial 2022–2023 (n = 15 392*).</p>

Figshare
Openalex Percentile: Top 62%
SARS-CoV-2 detection and testing
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

SARS-CoV-2 infections and circulating viral strains in South Africa during SHERPA trial 2022–2023 (n = 15 392*). · Figshare (2024) | TGRS Research Map | TGRS